SCHEMBL1610104

SCHEMBL1610104

[CH2]CCc1ccc(C(C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 2/20 0.41
FKBP1A P62942 1/20 0.40
PYCR1 P32322 1/20 0.40
RAB9A P51151 3/20 0.39
DHFR P00374 1/20 0.38
MAOB P27338 1/20 0.38
TYR P14679 1/20 0.38
NPC1 O15118 2/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
EPHX1 P07099 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 2/20 0.36
UCHL3 P15374 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610592 0.86 IDO1 (0.45) IDO1L3MBTL1ALDH1A1FKBP1APYCR1
SCHEMBL10729588 0.85 IDO1 (0.56) IDO1L3MBTL1ALDH1A1FKBP1APYCR1
SCHEMBL1610650 0.85 IDO1 (0.44) IDO1L3MBTL1ALDH1A1FKBP1APYCR1
SCHEMBL1611827 0.83 IDO1 (0.42) IDO1L3MBTL1ALDH1A1FKBP1APYCR1
SCHEMBL1611430 0.83 IDO1 (0.42) IDO1L3MBTL1ALDH1A1FKBP1APYCR1
SCHEMBL1609901 0.83 IDO1 (0.42) IDO1L3MBTL1ALDH1A1FKBP1APYCR1
SCHEMBL1611359 0.80 ALDH1A1 (0.40) L3MBTL1ALDH1A1RAB9ANPC1USP2
SCHEMBL330030 0.80 IDO1 (0.52) IDO1L3MBTL1PYCR1RAB9ATYR
SCHEMBL2745550 0.79 GFER (0.42) L3MBTL1ALDH1A1MAOBKMT2AKDM4E
SCHEMBL10140562 0.78 IDO1 (0.50) IDO1L3MBTL1ALDH1A1FKBP1APYCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1063064-A The surface treatment method of conductive copper powder BEIJING PRINTING TECH INST (CN) 1992-07-29 CN claimed
US-11718758-B2 Aqueous dispersion of colored particles MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
EP-3725854-B1 COLORED PARTICLE AQUEOUS DISPERSION MITSUBISHI PENCIL CO (JP) 2023-07-05 EP disclosed
US-20210071006-A1 AQUEOUS DISPERSION OF COLORED PARTICLES MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2021-03-11 US disclosed
EP-3725854-A1 COLORED PARTICLE AQUEOUS DISPERSION MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2020-10-21 EP disclosed
EP-3444304-A1 POLYFUNCTIONAL POLYMERIZABLE COMPOUND AND COLORED COMPOSITION FUJIFILM Wako Pure Chemical Corporation (JP) 2019-02-20 EP disclosed
CN-108473784-A Polyfunctional polymerizable compound and coloring composition 富士胶片和光纯药株式会社 2018-08-31 CN disclosed
US-20110087034-A1 Organic Semiconductor Material SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2011-04-14 US disclosed
EP-2248818-A1 ORGANIC SEMICONDUCTOR MATERIAL Sumitomo Chemical Company, Limited (JP) 2010-11-10 EP disclosed
CN-1914205-A Pyrazolo [3, 4-b ] pyridine compounds and their use as phosphodiesterase inhibitors GLAXO GROUP LTD (GB) 2007-02-14 CN disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed
CN-1036394-C Process for preparing quinolone derivatives OTSUKA PHARMA CO LTD (JP) 1997-11-12 CN disclosed
US-5430157-A Reduced phenanthrenes ELI LILLY AND COMPANY (US) 1995-07-04 US disclosed
US-5356935-A Reductase inhibitors ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
CN-1091288-A The oxytocin antagonist OTSUKA PHARMA CO LTD (JP) 1994-08-31 CN disclosed
CN-1063064-A The surface treatment method of conductive copper powder BEIJING PRINTING TECH INST (CN) 1992-07-29 CN disclosed
CN-1046529-A Carbostyril derivative OTSUKA PHARMA CO LTD (JP) 1990-10-31 CN disclosed
US-4337341-A 4a-Aryl-octahydro-1H-2-pyrindines ELI LILLY AND COMPANY (US) 1982-06-29 US disclosed
EP-0002937-A1 Novel pyrindines and their preparation, formulations and use ELI LILLY AND COMPANY (US) 1979-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110087034-A1 Organic Semiconductor Material OR10J3, TST, OR51E2 IDO1 174/4885L3MBTL1 236/4885ALDH1A1 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.